A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been ...

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

This is eight fewer than the FDA, which approved 46 novel drugs in 2025 – sneaking in two regulatory decisions during the ...

Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...

For years, the federal government advised Americans to limit red meat and foods high in saturated fats. However, new federal ...

More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new medicines, yet other leading pharmaceutical companies are hesitating over what ...

In early 2025, the FDA was rocked by sweeping layoffs and leadership turnover, raising questions about whether the agency ...

The Food and Drug Administration (FDA) on Friday said it has received at least 18 reports involving “health concerns” due to ...

It means there is a risk of 'serious adverse health consequences or death' if the product is consumed by certain people.

The U.S. Food and Drug Administration (FDA) has granted full approval of Laverdia, a drug to treat dogs with lymphoma, a type ...